Dextech Medical AB (XSAT:DEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.60
0.00 (0.00%)
At close: Sep 5, 2025

Dextech Medical AB Income Statement

Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
3.225.398.713.120.63
Upgrade
Revenue Growth (YoY)
-40.15%-38.18%179.60%390.65%6.48%
Upgrade
Cost of Revenue
8.54----
Upgrade
Gross Profit
-5.325.398.713.120.63
Upgrade
Selling, General & Admin
-7.2510.595.362.58
Upgrade
Operating Expenses
-10.9313.658.396.71
Upgrade
Operating Income
-5.32-5.55-4.94-5.27-6.08
Upgrade
Interest Expense
-----0
Upgrade
Interest & Investment Income
-0.840.35--
Upgrade
Other Non Operating Income (Expenses)
0.47----
Upgrade
Pretax Income
-4.85-4.71-4.59-5.27-6.08
Upgrade
Net Income
-4.85-4.71-4.59-5.27-6.08
Upgrade
Net Income to Common
-4.85-4.71-4.59-5.27-6.08
Upgrade
Shares Outstanding (Basic)
1819181715
Upgrade
Shares Outstanding (Diluted)
1819181715
Upgrade
Shares Change (YoY)
-1.79%2.51%8.02%14.72%-0.11%
Upgrade
EPS (Basic)
-0.26-0.25-0.25-0.31-0.41
Upgrade
EPS (Diluted)
-0.26-0.25-0.25-0.31-0.41
Upgrade
Gross Margin
-165.03%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-165.03%-103.04%-56.70%-169.14%-956.76%
Upgrade
Profit Margin
-150.33%-87.38%-52.70%-169.14%-956.77%
Upgrade
EBITDA
-1.19-5.39-4.77-5.03-5.81
Upgrade
EBITDA Margin
-36.79%-100.17%-54.78%-161.32%-
Upgrade
D&A For EBITDA
4.130.150.170.240.27
Upgrade
EBIT
-5.32-5.55-4.94-5.27-6.08
Upgrade
EBIT Margin
-165.03%-103.04%-56.70%-169.14%-
Upgrade
Revenue as Reported
-5.398.713.120.63
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.